Prospective Single-Site Experience with Radiofrequency-Targeted Vertebral Augmentation for Osteoporotic Vertebral Compression Fracture

Abstract EN

Vertebral augmentation procedures are widely used to treat osteoporotic vertebral compression fractures (VCFs).

We report our initial experience with radiofrequency-targeted vertebral augmentation (RF-TVA) in 20 patients aged 50 to 90 years with single-level, symptomatic osteoporotic VCF between T10 and L5, back pain severity > 4 on a 0 to 10 scale, Oswestry Disability Index ≥ 21%, 20% to 90% vertebral height loss compared to adjacent vertebral body, and fracture age < 6 months.

After treatment, patients were followed through hospital discharge and returned for visits after 1 week, 1 month, and 3 months.

Back pain severity improved 66% (P<0.001), from 7.9 (95% CI: 7.1 to 8.6) at pretreatment to 2.7 (95% CI: 1.5 to 4.0) at 3 months.

Back function improved 46% (P<0.001), from 74 (95% CI: 69% to 79%) at pretreatment to 40 (95% CI: 33% to 47%) at 3 months.

The percentage of patients regularly consuming pain medication was 70% at pretreatment and only 21% at 3 months.

No adverse events related to the device or procedure were reported.

RF-TVA reduces back pain severity, improves back function, and reduces pain medication requirements with no observed complications in patients with osteoporotic VCF.